ArticleDiabetologia2025

Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data.

Stephen O'Neill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.